BOLT - Company ID 0001641281
The table below shows Bolt Biotherapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $12.86M | $11.61M | $17.75M | $9.60M | $8.39M | $9.37M |
| Short-term investments | $4.74M | $11.28M | $14.16M | $25.17M | $30.45M | $44.43M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $20.56M |
| $25.75M |
| $35.61M |
| $38.34M |
| $42.51M |
| $57.15M |
| Property, plant & equipment | $571.00K | $1.04M | $1.50M | $1.72M | $2.06M | $3.56M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $40.34M | $48.03M | $65.05M | $75.50M | $85.86M | $109.33M |
| Accounts payable | $868.00K | $1.74M | $1.52M | $1.85M | $1.53M | $1.48M |
| Total current liabilities | $7.87M | $7.34M | $9.97M | $12.31M | $13.56M | $18.08M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $27.70M | $28.20M | $32.95M | $36.66M | $39.05M | $37.30M |
| Retained earnings | -$475.74M | -$468.02M | -$454.15M | -$447.00M | -$438.44M | -$411.47M |
| Total equity | $12.64M | $19.82M | $32.10M | $38.84M | $46.81M | $72.03M |